Recent Company News

• 09:05 AM ET Oct 20, 2025
  

  CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO

• 09:04 AM ET Oct 20, 2025
  

  Cumberland (CPIX) to invest $4M for a 30% ownership stake in RedHill's global Talicia business. ($1.50, 0.00)

• 09:01 AM ET Oct 20, 2025
  

  RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal

• 08:07 AM ET Oct 06, 2025
  

  RedHill Biopharma signs new $1.8M plus sales royalties Middle East deal for Talicia - 6-K ($1.90, 0.00)

• 08:01 AM ET Oct 06, 2025
  

  RedHill Biopharma Signs New $1.8 Million Plus Sales Royalties Middle East Deal For Talicia®

• 07:05 AM ET Sep 29, 2025
  

  RedHill announces New York Supreme Court upholds company's $10M summary Judgment against Kukbo ($1.84, 0.00)

• 07:01 AM ET Sep 29, 2025
  

  RedHill Wins New York Supreme Court Appeal, Upholding $10 Million Summary Judgment Against Kukbo

• 07:04 AM ET Sep 05, 2025
  

  RedHill Biopharma reports H1 gross profit $2.5M vs year-ago $1.2M ($1.23, 0.00)

• 07:00 AM ET Sep 05, 2025
  

  RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights

• 09:03 AM ET Aug 20, 2025
  

  RedHill Biopharma awarded $1.8M in legal costs and expenses by New York Supreme Court in addition to prior $8.25M summary Judgment win ($1.45, 0.00)